FibroBiologics, Inc. Conversion of Stock, Shares Converted
FibroBiologics, Inc. (FBLG) reported Conversion of Stock, Shares Converted of 18.07 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2026-02-24
- FibroBiologics, Inc. conversion of stock, shares converted for the quarter ending 2025-12-31 was 5.01M shares.
- FibroBiologics, Inc. conversion of stock, shares converted for the quarter ending 2025-09-30 was 7.40M shares.
- FibroBiologics, Inc. conversion of stock, shares converted for the quarter ending 2025-06-30 was 3.13M shares.
- FibroBiologics, Inc. conversion of stock, shares converted for the quarter ending 2025-03-31 was 2.53M shares.
- FibroBiologics, Inc. conversion of stock, shares converted for fiscal 2025 was 18.07M shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|
| 2025-12-31 | 5.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 12.41M shares derived: sum of 2 quarters · filed 2026-02-24 | 15.54M shares derived: sum of 3 quarters · filed 2026-02-24 | 18.07M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 7.40M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | 10.53M shares derived: sum of 2 quarters · filed 2025-10-31 | 13.06M shares 10-Q · filed 2025-10-31 | |
| 2025-06-30 | 3.13M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | 5.66M shares 10-Q · filed 2025-07-31 | ||
| 2025-03-31 | 2.53M shares 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |